Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulindac and epirubicin in advanced melanoma
NCT00755976Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Aug 2007
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sulindac in melanoma, sponsored by Cancer Trials Ireland. Started Aug 2007; status: completed.
02
Drugs
sulindac
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00755976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00755976.